Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01940393Phase 4Completed
A Phase 4 trial of cetirizine, desloratadine, fexofenadine, eribulin, bilastine in urticaria, sponsored by Grupo de Alergología Clínica y Experimental. Started Aug 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01940393.